nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A2—Carmustine—brain cancer	0.214	0.322	CbGbCtD
Toremifene—CYP3A4—Temozolomide—brain cancer	0.162	0.243	CbGbCtD
Toremifene—CYP3A4—Lomustine—brain cancer	0.137	0.207	CbGbCtD
Toremifene—CYP1A2—Etoposide—brain cancer	0.0634	0.0953	CbGbCtD
Toremifene—ABCB1—Etoposide—brain cancer	0.0554	0.0834	CbGbCtD
Toremifene—CYP3A4—Etoposide—brain cancer	0.0332	0.0499	CbGbCtD
Toremifene—Paresis—Temozolomide—brain cancer	0.00609	0.0248	CcSEcCtD
Toremifene—Thrombosis—Procarbazine—brain cancer	0.00519	0.0211	CcSEcCtD
Toremifene—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0051	0.062	CbGpPWpGaD
Toremifene—Disorder sight—Temozolomide—brain cancer	0.00467	0.019	CcSEcCtD
Toremifene—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00464	0.0564	CbGpPWpGaD
Toremifene—Lethargy—Lomustine—brain cancer	0.00429	0.0175	CcSEcCtD
Toremifene—Ataxia—Lomustine—brain cancer	0.00395	0.0161	CcSEcCtD
Toremifene—Deep vein thrombosis—Temozolomide—brain cancer	0.00365	0.0149	CcSEcCtD
Toremifene—Embolism—Temozolomide—brain cancer	0.00346	0.0141	CcSEcCtD
Toremifene—Cyst—Carmustine—brain cancer	0.00344	0.014	CcSEcCtD
Toremifene—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00325	0.0395	CbGpPWpGaD
Toremifene—Thrombosis—Carmustine—brain cancer	0.00325	0.0132	CcSEcCtD
Toremifene—Vaginal haemorrhage—Temozolomide—brain cancer	0.003	0.0122	CcSEcCtD
Toremifene—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00296	0.036	CbGpPWpGaD
Toremifene—Visual impairment—Lomustine—brain cancer	0.0028	0.0114	CcSEcCtD
Toremifene—Ospemifene—CYP2C9—brain cancer	0.00278	0.392	CrCbGaD
Toremifene—Lethargy—Procarbazine—brain cancer	0.00272	0.0111	CcSEcCtD
Toremifene—Rigors—Temozolomide—brain cancer	0.00272	0.0111	CcSEcCtD
Toremifene—Diplopia—Procarbazine—brain cancer	0.00267	0.0109	CcSEcCtD
Toremifene—Alopecia—Lomustine—brain cancer	0.00257	0.0105	CcSEcCtD
Toremifene—Ataxia—Procarbazine—brain cancer	0.00251	0.0102	CcSEcCtD
Toremifene—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00245	0.0298	CbGpPWpGaD
Toremifene—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00236	0.0287	CbGpPWpGaD
Toremifene—Coordination abnormal—Carmustine—brain cancer	0.00234	0.00953	CcSEcCtD
Toremifene—Pulmonary embolism—Carmustine—brain cancer	0.0023	0.00936	CcSEcCtD
Toremifene—Leukopenia—Lomustine—brain cancer	0.00226	0.00922	CcSEcCtD
Toremifene—Coordination abnormal—Temozolomide—brain cancer	0.00226	0.00921	CcSEcCtD
Toremifene—Angina pectoris—Procarbazine—brain cancer	0.00225	0.00914	CcSEcCtD
Toremifene—Pulmonary embolism—Temozolomide—brain cancer	0.00222	0.00905	CcSEcCtD
Toremifene—Rigors—Etoposide—brain cancer	0.00218	0.00886	CcSEcCtD
Toremifene—ESR1—LKB1 signaling events—STRADA—brain cancer	0.00211	0.0257	CbGpPWpGaD
Toremifene—Dry eye—Temozolomide—brain cancer	0.00205	0.00835	CcSEcCtD
Toremifene—Thrombocytopenia—Lomustine—brain cancer	0.00202	0.00823	CcSEcCtD
Toremifene—Pain—Carboplatin—brain cancer	0.00202	0.00822	CcSEcCtD
Toremifene—Neuropathy peripheral—Procarbazine—brain cancer	0.00201	0.0082	CcSEcCtD
Toremifene—Abnormal vision—Carmustine—brain cancer	0.00201	0.00816	CcSEcCtD
Toremifene—Jaundice—Procarbazine—brain cancer	0.002	0.00816	CcSEcCtD
Toremifene—Sweating—Procarbazine—brain cancer	0.00197	0.00802	CcSEcCtD
Toremifene—Anorexia—Lomustine—brain cancer	0.00197	0.00801	CcSEcCtD
Toremifene—Skin discolouration—Etoposide—brain cancer	0.00197	0.00801	CcSEcCtD
Toremifene—Abnormal vision—Temozolomide—brain cancer	0.00194	0.00789	CcSEcCtD
Toremifene—Thrombophlebitis—Carmustine—brain cancer	0.00193	0.00785	CcSEcCtD
Toremifene—Breast disorder—Hydroxyurea—brain cancer	0.00187	0.00759	CcSEcCtD
Toremifene—Thrombophlebitis—Temozolomide—brain cancer	0.00186	0.00758	CcSEcCtD
Toremifene—Decreased appetite—Lomustine—brain cancer	0.0018	0.00731	CcSEcCtD
Toremifene—Hot flush—Temozolomide—brain cancer	0.00172	0.00702	CcSEcCtD
Toremifene—Menopausal symptoms—Temozolomide—brain cancer	0.00171	0.00696	CcSEcCtD
Toremifene—Diplopia—Carmustine—brain cancer	0.00167	0.00679	CcSEcCtD
Toremifene—Chills—Procarbazine—brain cancer	0.00166	0.00674	CcSEcCtD
Toremifene—Arrhythmia—Procarbazine—brain cancer	0.00165	0.00671	CcSEcCtD
Toremifene—Alopecia—Procarbazine—brain cancer	0.00163	0.00664	CcSEcCtD
Toremifene—Weight increased—Hydroxyurea—brain cancer	0.00162	0.00661	CcSEcCtD
Toremifene—Diplopia—Temozolomide—brain cancer	0.00161	0.00657	CcSEcCtD
Toremifene—Affect lability—Temozolomide—brain cancer	0.00159	0.00646	CcSEcCtD
Toremifene—ESR1—Nuclear signaling by ERBB4—GFAP—brain cancer	0.00158	0.0193	CbGpPWpGaD
Toremifene—Ataxia—Carmustine—brain cancer	0.00157	0.00639	CcSEcCtD
Toremifene—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00156	0.019	CbGpPWpGaD
Toremifene—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00156	0.00635	CcSEcCtD
Toremifene—Liver function test abnormal—Carmustine—brain cancer	0.00154	0.00627	CcSEcCtD
Toremifene—Mood swings—Temozolomide—brain cancer	0.00153	0.00622	CcSEcCtD
Toremifene—Ataxia—Temozolomide—brain cancer	0.00152	0.00617	CcSEcCtD
Toremifene—Tremor—Procarbazine—brain cancer	0.00151	0.00613	CcSEcCtD
Toremifene—Hepatobiliary disease—Hydroxyurea—brain cancer	0.0015	0.00613	CcSEcCtD
Toremifene—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.0015	0.0183	CbGpPWpGaD
Toremifene—Breast disorder—Temozolomide—brain cancer	0.00146	0.00593	CcSEcCtD
Toremifene—Leukopenia—Procarbazine—brain cancer	0.00144	0.00585	CcSEcCtD
Toremifene—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00134	0.0163	CbGpPWpGaD
Toremifene—Dextropropoxyphene—CYP2C9—brain cancer	0.00132	0.187	CrCbGaD
Toremifene—Cardiac failure—Etoposide—brain cancer	0.00132	0.00538	CcSEcCtD
Toremifene—Vomiting—Lomustine—brain cancer	0.00131	0.00535	CcSEcCtD
Toremifene—Oedema—Procarbazine—brain cancer	0.00131	0.00534	CcSEcCtD
Toremifene—Angiopathy—Hydroxyurea—brain cancer	0.0013	0.00527	CcSEcCtD
Toremifene—Thrombocytopenia—Procarbazine—brain cancer	0.00128	0.00523	CcSEcCtD
Toremifene—Chills—Hydroxyurea—brain cancer	0.00128	0.00522	CcSEcCtD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00128	0.0156	CbGpPWpGaD
Toremifene—Weight increased—Temozolomide—brain cancer	0.00127	0.00516	CcSEcCtD
Toremifene—Hyperhidrosis—Procarbazine—brain cancer	0.00127	0.00516	CcSEcCtD
Toremifene—Alopecia—Hydroxyurea—brain cancer	0.00126	0.00514	CcSEcCtD
Toremifene—Neuropathy peripheral—Carmustine—brain cancer	0.00126	0.00513	CcSEcCtD
Toremifene—Anorexia—Procarbazine—brain cancer	0.00125	0.00509	CcSEcCtD
Toremifene—Nausea—Lomustine—brain cancer	0.00123	0.00499	CcSEcCtD
Toremifene—Neuropathy peripheral—Temozolomide—brain cancer	0.00122	0.00496	CcSEcCtD
Toremifene—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00121	0.0147	CbGpPWpGaD
Toremifene—Insomnia—Procarbazine—brain cancer	0.00119	0.00483	CcSEcCtD
Toremifene—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00118	0.0143	CbGpPWpGaD
Toremifene—Hepatobiliary disease—Temozolomide—brain cancer	0.00118	0.00479	CcSEcCtD
Toremifene—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00116	0.0141	CbGpPWpGaD
Toremifene—Tamoxifen—ESR2—brain cancer	0.00115	0.163	CrCbGaD
Toremifene—Decreased appetite—Procarbazine—brain cancer	0.00114	0.00464	CcSEcCtD
Toremifene—ESR1—FOXA1 transcription factor network—SHH—brain cancer	0.00114	0.0138	CbGpPWpGaD
Toremifene—Fatigue—Procarbazine—brain cancer	0.00113	0.0046	CcSEcCtD
Toremifene—Pain—Procarbazine—brain cancer	0.00112	0.00456	CcSEcCtD
Toremifene—Constipation—Procarbazine—brain cancer	0.00112	0.00456	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—SKP2—brain cancer	0.00112	0.0136	CbGpPWpGaD
Toremifene—Leukopenia—Hydroxyurea—brain cancer	0.00111	0.00453	CcSEcCtD
Toremifene—Visual impairment—Carmustine—brain cancer	0.00111	0.00453	CcSEcCtD
Toremifene—Eye disorder—Carmustine—brain cancer	0.00108	0.00439	CcSEcCtD
Toremifene—Visual impairment—Temozolomide—brain cancer	0.00108	0.00438	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00105	0.00428	CcSEcCtD
Toremifene—Eye disorder—Temozolomide—brain cancer	0.00104	0.00424	CcSEcCtD
Toremifene—Arrhythmia—Carmustine—brain cancer	0.00103	0.0042	CcSEcCtD
Toremifene—ESR1—Nuclear Receptors—ESR2—brain cancer	0.00102	0.0124	CbGpPWpGaD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00102	0.0124	CbGpPWpGaD
Toremifene—Alopecia—Carmustine—brain cancer	0.00102	0.00415	CcSEcCtD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00102	0.0124	CbGpPWpGaD
Toremifene—Oedema—Hydroxyurea—brain cancer	0.00101	0.00413	CcSEcCtD
Toremifene—Angiopathy—Temozolomide—brain cancer	0.00101	0.00412	CcSEcCtD
Toremifene—Mental disorder—Carmustine—brain cancer	0.00101	0.00412	CcSEcCtD
Toremifene—Mediastinal disorder—Temozolomide—brain cancer	0.00101	0.00409	CcSEcCtD
Toremifene—Malnutrition—Carmustine—brain cancer	0.00101	0.00409	CcSEcCtD
Toremifene—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.001	0.0122	CbGpPWpGaD
Toremifene—Chills—Temozolomide—brain cancer	0.001	0.00408	CcSEcCtD
Toremifene—Nervous system disorder—Hydroxyurea—brain cancer	0.000995	0.00405	CcSEcCtD
Toremifene—Thrombocytopenia—Hydroxyurea—brain cancer	0.000993	0.00404	CcSEcCtD
Toremifene—Alopecia—Temozolomide—brain cancer	0.000986	0.00401	CcSEcCtD
Toremifene—Skin disorder—Hydroxyurea—brain cancer	0.000986	0.00401	CcSEcCtD
Toremifene—Acute coronary syndrome—Etoposide—brain cancer	0.00098	0.00399	CcSEcCtD
Toremifene—Mental disorder—Temozolomide—brain cancer	0.000977	0.00398	CcSEcCtD
Toremifene—Neuropathy peripheral—Etoposide—brain cancer	0.000975	0.00397	CcSEcCtD
Toremifene—Myocardial infarction—Etoposide—brain cancer	0.000975	0.00397	CcSEcCtD
Toremifene—Back pain—Carmustine—brain cancer	0.000972	0.00396	CcSEcCtD
Toremifene—Malnutrition—Temozolomide—brain cancer	0.000971	0.00395	CcSEcCtD
Toremifene—Jaundice—Etoposide—brain cancer	0.000969	0.00395	CcSEcCtD
Toremifene—Anorexia—Hydroxyurea—brain cancer	0.000967	0.00394	CcSEcCtD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—ESR2—brain cancer	0.000963	0.0117	CbGpPWpGaD
Toremifene—Vision blurred—Carmustine—brain cancer	0.000947	0.00386	CcSEcCtD
Toremifene—Tremor—Carmustine—brain cancer	0.000942	0.00383	CcSEcCtD
Toremifene—Asthenia—Procarbazine—brain cancer	0.000941	0.00383	CcSEcCtD
Toremifene—Hepatobiliary disease—Etoposide—brain cancer	0.000941	0.00383	CcSEcCtD
Toremifene—Back pain—Temozolomide—brain cancer	0.000939	0.00382	CcSEcCtD
Toremifene—Diphenhydramine—CYP2C9—brain cancer	0.000929	0.131	CrCbGaD
Toremifene—Pruritus—Procarbazine—brain cancer	0.000928	0.00378	CcSEcCtD
Toremifene—Vision blurred—Temozolomide—brain cancer	0.000915	0.00373	CcSEcCtD
Toremifene—Tremor—Temozolomide—brain cancer	0.00091	0.0037	CcSEcCtD
Toremifene—Tamoxifen—CYP2C9—brain cancer	0.000905	0.128	CrCbGaD
Toremifene—Dyspnoea—Hydroxyurea—brain cancer	0.000905	0.00368	CcSEcCtD
Toremifene—Leukopenia—Carmustine—brain cancer	0.0009	0.00366	CcSEcCtD
Toremifene—Decreased appetite—Hydroxyurea—brain cancer	0.000882	0.00359	CcSEcCtD
Toremifene—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000876	0.00357	CcSEcCtD
Toremifene—Fatigue—Hydroxyurea—brain cancer	0.000875	0.00356	CcSEcCtD
Toremifene—Vertigo—Temozolomide—brain cancer	0.000873	0.00355	CcSEcCtD
Toremifene—Leukopenia—Temozolomide—brain cancer	0.000869	0.00354	CcSEcCtD
Toremifene—Constipation—Hydroxyurea—brain cancer	0.000868	0.00353	CcSEcCtD
Toremifene—Pain—Hydroxyurea—brain cancer	0.000868	0.00353	CcSEcCtD
Toremifene—Dizziness—Procarbazine—brain cancer	0.000867	0.00353	CcSEcCtD
Toremifene—Chest pain—Carmustine—brain cancer	0.000856	0.00348	CcSEcCtD
Toremifene—Eye disorder—Etoposide—brain cancer	0.000834	0.0034	CcSEcCtD
Toremifene—Vomiting—Procarbazine—brain cancer	0.000834	0.00339	CcSEcCtD
Toremifene—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000828	0.0101	CbGpPWpGaD
Toremifene—Rash—Procarbazine—brain cancer	0.000827	0.00337	CcSEcCtD
Toremifene—Dermatitis—Procarbazine—brain cancer	0.000826	0.00336	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000825	0.01	CbGpPWpGaD
Toremifene—Headache—Procarbazine—brain cancer	0.000821	0.00334	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000821	0.00334	CcSEcCtD
Toremifene—Oedema—Carmustine—brain cancer	0.00082	0.00334	CcSEcCtD
Toremifene—ESR1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000819	0.00997	CbGpPWpGaD
Toremifene—Angiopathy—Etoposide—brain cancer	0.00081	0.0033	CcSEcCtD
Toremifene—ESR1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000809	0.00984	CbGpPWpGaD
Toremifene—Mediastinal disorder—Etoposide—brain cancer	0.000805	0.00328	CcSEcCtD
Toremifene—Thrombocytopenia—Carmustine—brain cancer	0.000803	0.00327	CcSEcCtD
Toremifene—Chills—Etoposide—brain cancer	0.000801	0.00326	CcSEcCtD
Toremifene—Oedema—Temozolomide—brain cancer	0.000793	0.00323	CcSEcCtD
Toremifene—Alopecia—Etoposide—brain cancer	0.000789	0.00321	CcSEcCtD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000788	0.00959	CbGpPWpGaD
Toremifene—Anorexia—Carmustine—brain cancer	0.000782	0.00318	CcSEcCtD
Toremifene—Nausea—Procarbazine—brain cancer	0.000779	0.00317	CcSEcCtD
Toremifene—Nervous system disorder—Temozolomide—brain cancer	0.000777	0.00316	CcSEcCtD
Toremifene—Thrombocytopenia—Temozolomide—brain cancer	0.000776	0.00316	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—BRCA2—brain cancer	0.000776	0.00944	CbGpPWpGaD
Toremifene—Skin disorder—Temozolomide—brain cancer	0.00077	0.00313	CcSEcCtD
Toremifene—Hyperhidrosis—Temozolomide—brain cancer	0.000766	0.00312	CcSEcCtD
Toremifene—Anorexia—Temozolomide—brain cancer	0.000756	0.00308	CcSEcCtD
Toremifene—Back pain—Etoposide—brain cancer	0.000752	0.00306	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—CCNE1—brain cancer	0.000751	0.00914	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00075	0.00913	CbGpPWpGaD
Toremifene—Insomnia—Carmustine—brain cancer	0.000742	0.00302	CcSEcCtD
Toremifene—Dyspnoea—Carmustine—brain cancer	0.000731	0.00298	CcSEcCtD
Toremifene—Asthenia—Hydroxyurea—brain cancer	0.000728	0.00296	CcSEcCtD
Toremifene—Insomnia—Temozolomide—brain cancer	0.000717	0.00292	CcSEcCtD
Toremifene—Decreased appetite—Carmustine—brain cancer	0.000713	0.0029	CcSEcCtD
Toremifene—Gastrointestinal disorder—Carmustine—brain cancer	0.000708	0.00288	CcSEcCtD
Toremifene—Dyspnoea—Temozolomide—brain cancer	0.000707	0.00288	CcSEcCtD
Toremifene—Pain—Carmustine—brain cancer	0.000701	0.00286	CcSEcCtD
Toremifene—Constipation—Carmustine—brain cancer	0.000701	0.00286	CcSEcCtD
Toremifene—Vertigo—Etoposide—brain cancer	0.000698	0.00284	CcSEcCtD
Toremifene—Leukopenia—Etoposide—brain cancer	0.000696	0.00283	CcSEcCtD
Toremifene—Decreased appetite—Temozolomide—brain cancer	0.000689	0.00281	CcSEcCtD
Toremifene—Gastrointestinal disorder—Temozolomide—brain cancer	0.000684	0.00279	CcSEcCtD
Toremifene—Fatigue—Temozolomide—brain cancer	0.000683	0.00278	CcSEcCtD
Toremifene—Pain—Temozolomide—brain cancer	0.000678	0.00276	CcSEcCtD
Toremifene—Constipation—Temozolomide—brain cancer	0.000678	0.00276	CcSEcCtD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.000674	0.0082	CbGpPWpGaD
Toremifene—Dizziness—Hydroxyurea—brain cancer	0.000671	0.00273	CcSEcCtD
Toremifene—Chest pain—Etoposide—brain cancer	0.000662	0.00269	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000657	0.00268	CcSEcCtD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000649	0.00789	CbGpPWpGaD
Toremifene—Vomiting—Hydroxyurea—brain cancer	0.000645	0.00263	CcSEcCtD
Toremifene—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00064	0.00778	CbGpPWpGaD
Toremifene—Rash—Hydroxyurea—brain cancer	0.00064	0.0026	CcSEcCtD
Toremifene—Dermatitis—Hydroxyurea—brain cancer	0.000639	0.0026	CcSEcCtD
Toremifene—Headache—Hydroxyurea—brain cancer	0.000636	0.00259	CcSEcCtD
Toremifene—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000635	0.00772	CbGpPWpGaD
Toremifene—Thrombocytopenia—Etoposide—brain cancer	0.000621	0.00253	CcSEcCtD
Toremifene—Skin disorder—Etoposide—brain cancer	0.000616	0.00251	CcSEcCtD
Toremifene—Hyperhidrosis—Etoposide—brain cancer	0.000613	0.0025	CcSEcCtD
Toremifene—Anorexia—Etoposide—brain cancer	0.000605	0.00246	CcSEcCtD
Toremifene—Nausea—Hydroxyurea—brain cancer	0.000603	0.00245	CcSEcCtD
Toremifene—Asthenia—Carmustine—brain cancer	0.000588	0.0024	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—CDK4—brain cancer	0.000575	0.007	CbGpPWpGaD
Toremifene—Asthenia—Temozolomide—brain cancer	0.000569	0.00232	CcSEcCtD
Toremifene—Dyspnoea—Etoposide—brain cancer	0.000565	0.0023	CcSEcCtD
Toremifene—Pruritus—Temozolomide—brain cancer	0.000561	0.00228	CcSEcCtD
Toremifene—ESR1—ATF-2 transcription factor network—HES1—brain cancer	0.000559	0.0068	CbGpPWpGaD
Toremifene—Decreased appetite—Etoposide—brain cancer	0.000551	0.00224	CcSEcCtD
Toremifene—Gastrointestinal disorder—Etoposide—brain cancer	0.000548	0.00223	CcSEcCtD
Toremifene—Fatigue—Etoposide—brain cancer	0.000547	0.00223	CcSEcCtD
Toremifene—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000543	0.0066	CbGpPWpGaD
Toremifene—Dizziness—Carmustine—brain cancer	0.000542	0.00221	CcSEcCtD
Toremifene—Pain—Etoposide—brain cancer	0.000542	0.00221	CcSEcCtD
Toremifene—Constipation—Etoposide—brain cancer	0.000542	0.00221	CcSEcCtD
Toremifene—ESR1—Signaling by ERBB4—GFAP—brain cancer	0.000534	0.00649	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—PDGFRA—brain cancer	0.000532	0.00647	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000526	0.0064	CbGpPWpGaD
Toremifene—Dizziness—Temozolomide—brain cancer	0.000524	0.00213	CcSEcCtD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000523	0.00637	CbGpPWpGaD
Toremifene—Vomiting—Carmustine—brain cancer	0.000522	0.00212	CcSEcCtD
Toremifene—Rash—Carmustine—brain cancer	0.000517	0.00211	CcSEcCtD
Toremifene—Dermatitis—Carmustine—brain cancer	0.000517	0.0021	CcSEcCtD
Toremifene—Headache—Carmustine—brain cancer	0.000514	0.00209	CcSEcCtD
Toremifene—Vomiting—Temozolomide—brain cancer	0.000504	0.00205	CcSEcCtD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000501	0.00609	CbGpPWpGaD
Toremifene—Rash—Temozolomide—brain cancer	0.0005	0.00203	CcSEcCtD
Toremifene—Dermatitis—Temozolomide—brain cancer	0.000499	0.00203	CcSEcCtD
Toremifene—Headache—Temozolomide—brain cancer	0.000497	0.00202	CcSEcCtD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000494	0.00601	CbGpPWpGaD
Toremifene—Nausea—Carmustine—brain cancer	0.000487	0.00198	CcSEcCtD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000475	0.00578	CbGpPWpGaD
Toremifene—Nausea—Temozolomide—brain cancer	0.000471	0.00192	CcSEcCtD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000467	0.00567	CbGpPWpGaD
Toremifene—Asthenia—Etoposide—brain cancer	0.000455	0.00185	CcSEcCtD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000452	0.0055	CbGpPWpGaD
Toremifene—Pruritus—Etoposide—brain cancer	0.000449	0.00183	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—CDKN2A—brain cancer	0.00044	0.00535	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—CDK4—brain cancer	0.000438	0.00533	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000438	0.00533	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000432	0.00525	CbGpPWpGaD
Toremifene—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000425	0.00517	CbGpPWpGaD
Toremifene—Dizziness—Etoposide—brain cancer	0.000419	0.00171	CcSEcCtD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000406	0.00494	CbGpPWpGaD
Toremifene—Vomiting—Etoposide—brain cancer	0.000403	0.00164	CcSEcCtD
Toremifene—Rash—Etoposide—brain cancer	0.0004	0.00163	CcSEcCtD
Toremifene—Dermatitis—Etoposide—brain cancer	0.0004	0.00163	CcSEcCtD
Toremifene—Headache—Etoposide—brain cancer	0.000397	0.00162	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000393	0.00479	CbGpPWpGaD
Toremifene—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000377	0.00459	CbGpPWpGaD
Toremifene—Nausea—Etoposide—brain cancer	0.000377	0.00153	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—CCND1—brain cancer	0.000371	0.00452	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000351	0.00427	CbGpPWpGaD
Toremifene—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000346	0.00421	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.00034	0.00414	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000333	0.00405	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000327	0.00397	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—VAV1—brain cancer	0.000305	0.00371	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000301	0.00366	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—MYC—brain cancer	0.000298	0.00362	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—MYC—brain cancer	0.000292	0.00356	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000292	0.00355	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000288	0.0035	CbGpPWpGaD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000283	0.00344	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—CCND1—brain cancer	0.000283	0.00344	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000281	0.00342	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000279	0.0034	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000279	0.00339	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000277	0.00337	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000275	0.00335	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000273	0.00332	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000271	0.0033	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—RELA—brain cancer	0.000266	0.00324	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000265	0.00323	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—ERBB2—brain cancer	0.000264	0.00322	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000261	0.00317	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—IL2—brain cancer	0.000259	0.00315	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL2—brain cancer	0.000253	0.00308	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—CCND1—brain cancer	0.000253	0.00307	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PDGFRA—brain cancer	0.00025	0.00304	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CCND1—brain cancer	0.000247	0.003	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000244	0.00297	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—TP53—brain cancer	0.00024	0.00292	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000235	0.00286	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—CCND1—brain cancer	0.000234	0.00284	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000231	0.00281	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000226	0.00275	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000224	0.00272	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000223	0.00271	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IRS2—brain cancer	0.000219	0.00267	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000216	0.00262	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000213	0.00259	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000213	0.00259	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000208	0.00253	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000207	0.00251	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—MYC—brain cancer	0.000203	0.00247	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—STAT3—brain cancer	0.000202	0.00245	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000199	0.00243	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—EGFR—brain cancer	0.000198	0.00241	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000198	0.00241	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MYC—brain cancer	0.000198	0.00241	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000186	0.00226	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000184	0.00223	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.00018	0.00218	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.00018	0.00218	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000176	0.00214	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000176	0.00214	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000171	0.00208	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000168	0.00205	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000166	0.00202	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—OR4C12—brain cancer	0.000165	0.002	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—OR14C36—brain cancer	0.000165	0.002	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TP53—brain cancer	0.000163	0.00198	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000161	0.00196	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000154	0.00188	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—ERBB2—brain cancer	0.00015	0.00183	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.00015	0.00182	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000149	0.00181	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DTX2—brain cancer	0.00014	0.0017	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—ESR2—brain cancer	0.00014	0.0017	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000139	0.0017	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000133	0.00162	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000132	0.00161	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000132	0.00161	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000127	0.00155	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000125	0.00152	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000123	0.0015	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000122	0.00149	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL2—brain cancer	0.000122	0.00148	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00012	0.00146	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000119	0.00145	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000118	0.00144	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000117	0.00142	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000116	0.00142	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000114	0.00139	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000114	0.00139	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000111	0.00135	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00011	0.00134	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.00011	0.00133	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000107	0.0013	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000107	0.0013	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTCH2—brain cancer	0.000106	0.00129	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000105	0.00128	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000105	0.00127	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—EGFR—brain cancer	0.000104	0.00127	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—brain cancer	0.000103	0.00126	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HES5—brain cancer	0.000103	0.00125	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STRADA—brain cancer	9.97e-05	0.00121	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.64e-05	0.00117	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.06e-05	0.0011	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.87e-05	0.00108	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	8.79e-05	0.00107	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.68e-05	0.00106	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	8.53e-05	0.00104	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ABR—brain cancer	8.32e-05	0.00101	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GLI2—brain cancer	8.04e-05	0.000978	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.84e-05	0.000954	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GLI1—brain cancer	7.56e-05	0.000919	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—DNMT1—brain cancer	7.49e-05	0.000911	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2C9—brain cancer	7.49e-05	0.000911	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.28e-05	0.000886	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SUFU—brain cancer	7.17e-05	0.000872	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.12e-05	0.000866	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GFAP—brain cancer	6.91e-05	0.000841	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—ESR2—brain cancer	6.73e-05	0.000818	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.62e-05	0.000806	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HEY1—brain cancer	6.55e-05	0.000797	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DLL1—brain cancer	6.43e-05	0.000782	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH2—brain cancer	6.37e-05	0.000775	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—BSG—brain cancer	6.37e-05	0.000775	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2C9—brain cancer	5.98e-05	0.000728	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.85e-05	0.000712	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.79e-05	0.000705	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—IDH1—brain cancer	5.48e-05	0.000666	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SHH—brain cancer	5.46e-05	0.000665	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SIRT1—brain cancer	5.42e-05	0.000659	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TRPC6—brain cancer	5.27e-05	0.000641	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SMO—brain cancer	5.18e-05	0.00063	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTCH1—brain cancer	5.18e-05	0.00063	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.1e-05	0.000621	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BSG—brain cancer	5.09e-05	0.000619	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2C9—brain cancer	4.78e-05	0.000581	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.69e-05	0.000571	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.59e-05	0.000558	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.46e-05	0.000542	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—brain cancer	4.41e-05	0.000536	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—IDH1—brain cancer	4.37e-05	0.000532	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ENO2—brain cancer	4.33e-05	0.000527	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH2—brain cancer	4.14e-05	0.000504	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BSG—brain cancer	4.06e-05	0.000494	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VAV1—brain cancer	3.95e-05	0.00048	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.85e-05	0.000469	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2C9—brain cancer	3.69e-05	0.000448	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—IDH1—brain cancer	3.49e-05	0.000425	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ENO2—brain cancer	3.46e-05	0.000421	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HES1—brain cancer	3.4e-05	0.000413	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFRA—brain cancer	3.23e-05	0.000393	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SPP1—brain cancer	3.14e-05	0.000382	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BSG—brain cancer	3.13e-05	0.000381	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.84e-05	0.000346	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS2—brain cancer	2.84e-05	0.000345	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ENO2—brain cancer	2.76e-05	0.000336	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—IDH1—brain cancer	2.69e-05	0.000328	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—brain cancer	2.51e-05	0.000305	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APC—brain cancer	2.51e-05	0.000305	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ENO2—brain cancer	2.13e-05	0.000259	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—brain cancer	2.12e-05	0.000258	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—brain cancer	1.99e-05	0.000242	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RELA—brain cancer	1.96e-05	0.000238	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB2—brain cancer	1.95e-05	0.000237	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—brain cancer	1.76e-05	0.000215	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—brain cancer	1.72e-05	0.000209	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CTNNB1—brain cancer	1.7e-05	0.000207	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—brain cancer	1.59e-05	0.000193	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—brain cancer	1.5e-05	0.000182	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—brain cancer	1.48e-05	0.000181	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—brain cancer	1.38e-05	0.000168	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—brain cancer	1.35e-05	0.000164	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—brain cancer	1.27e-05	0.000154	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—brain cancer	1.13e-05	0.000138	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—brain cancer	9.77e-06	0.000119	CbGpPWpGaD
